ems limited has moved to consolidate its control over Mirzapur Ghazipur STPs Private Limited by acquiring an additional 14% stake in the subsidiary. The company entered into a Share Purchase Agreement (SPA) on July 31, 2026, to purchase 140 equity shares for a total consideration of ₹26.08 Lakhs, or ₹18,629 per share. Upon completion, EMS Limited’s holding will rise from 60% to 74% of the target entity’s paid-up share capital. The move aligns with the company’s strategy to deepen its presence in the sewage treatment plant (STP) development sector, where the subsidiary operates.

The transaction is structured as a related-party transaction under Section 2(76) of the Companies Act, 2013, as Ashish Tomar, Managing Director & CFO of EMS Limited, also serves as a Director in Mirzapur Ghazipur STPs Private Limited. The company confirmed that the deal is being executed on an arm’s-length basis, with consideration determined by a valuation report from a registered valuer. No governmental or regulatory approvals are required for this acquisition. EMS Limited expects to complete the share transfer within 30–90 days.

Mirzapur Ghazipur STPs Private Limited, incorporated on March 15, 2021, is engaged in the development and installation of Sewage Treatment Plants (STPs). Its registered office is located in New Delhi. The subsidiary’s financial performance shows a significant turnaround in profitability during FY25-26, despite a decline in turnover compared to FY23-24.

Financial Performance of Mirzapur Ghazipur STPs Private Limited

The subsidiary reported a turnover of ₹2,086.02 Lakhs in FY25-26, down from ₹2,303.76 Lakhs in FY24-25 and significantly lower than ₹7,876.35 Lakhs in FY23-24. However, Profit After Tax (PAT) surged to ₹109.80 Lakhs in FY25-26, a sharp increase from ₹1.75 Lakhs in FY24-25 and ₹0.92 Lakhs in FY23-24. Net worth also doubled to ₹221.32 Lakhs in FY25-26 from ₹111.52 Lakhs in the previous year.

What the Numbers Show

The financial data reveals a divergence between revenue trends and profitability at the subsidiary level. While turnover contracted by approximately 70% from FY23-24 to FY25-26, PAT expanded more than 100-fold over the same period. This suggests that the recent profitability surge in FY25-26 may not be driven by operational scale but potentially by non-operational factors or margin improvements on a smaller revenue base. Investors should monitor whether this profit growth is sustainable as EMS Limited increases its control to 74%.

Ems has been awarded a confirmed work order valued at Rs 15,828.57 lakh (Rs 158.29 crore) by Delhi Jal Board. The scope involves providing, laying, and jointing internal and peripheral sewer lines in Tikri Kalan GOC under the command of a proposed Sewage Treatment Plant (STP). The execution timeline for this project is set at 15 months. This is a Type A confirmed order, meaning the value is firm and executable upon mobilization. The company's market capitalisation has reached Rs 2,000 crore.

Order In Financial Context

The new order value represents approximately 84.90% of the company's average quarterly revenue of Rs 186.40 crore. When added to the existing pipeline, the Total Disclosed Order Book stands at Rs 167,132.56 crore across 13 orders (sum of the 13 orders disclosed across the last 3 fiscal quarters shown in the table below). This results in a book-to-bill ratio that implies the total order book covers 896.63 quarters of average quarterly revenue. Such a high coverage figure suggests that execution capacity, rather than order acquisition, is likely the primary constraint on near-term revenue growth.

Company Order Track Record

Order inflow velocity has shown significant variation over the last two available quarters. Q1FY27 saw a massive inflow of Rs 104,027.36 crore, primarily driven by large contracts from UP Jal Nigam. In Q2FY27, inflows moderated to Rs 63,105.20 crore but diversified slightly with the addition of Delhi Jal Board as a client alongside UP Jal Nigam. The current order size is consistent with the company's typical per-order magnitude visible in recent history, which frequently exceeds Rs 10,000 lakh.

Execution And Revenue Quality

Consolidated revenue has shown a declining trend over the last three quarters, dropping from Rs 202.90 crore in Q3FY26 to Rs 123.60 crore in Q4FY26. Correspondingly, net profit fell sharply from Rs 28.10 crore to Rs 5.70 crore in the same period. Operating Profit Margin (OPM) compressed from 21.43% in Q2FY26 to 15.20% in Q4FY26, indicating margin pressure or lower utilization during the most recent quarter.

Revenue Growth — Order Wins Translating To Revenue

As Ems has sustained significant order wins, with quarterly inflows exceeding Rs 63,000 crore in recent periods, its annual revenue has declined from Rs 981.70 crore in FY25 to Rs 732.75 crore in FY26, representing a YoY growth of -25.40% based on the latest annual data. This divergence between massive order book accumulation and declining realized revenue highlights a lag in execution or revenue recognition timing relative to order awards.

Working Capital And Execution Capacity

The balance sheet appears robust for executing the current backlog. The current ratio stands at 5.14x, indicating strong short-term liquidity. Total Liabilities/Equity is low at 0.26x, reflecting minimal leverage. Operating cashflow was positive at Rs 33.50 crore in FY25, following a negative year in FY24 (-Rs 115.90 crore). This recovery in cash generation supports the company's ability to fund working capital needs for ongoing projects without excessive external borrowing.

What To Watch

• Execution rate: With a backlog covering nearly 900 quarters of average revenue, monitoring whether quarterly revenue run-rates accelerate to convert this paper backlog into actual sales is key.
• OPM trajectory: Recent quarters show margin compression (15.20% in Q4FY26 vs 21.43% in Q2FY26); watch if new orders maintain historical margin quality.
• Client concentration: UP Jal Nigam accounts for the majority of the disclosed order book; any delay or dispute with this single entity could significantly impact revenue realization.
• Cash conversion: Ensure positive operating cashflows are sustained as project volumes scale up, preventing receivables buildup.

Key Observations

• Backlog signal: Book-to-bill of 896.63x coverage. At this level, execution capacity becomes the binding constraint.
• Market cap: Rs 2,000 crore as of the latest data.
• Valuation check (as of 31 Jul 2026): P/E of 23.40x against ROCE of 23.98%. Valuation was pricing in execution improvement not yet visible in return ratios.
• Margin stress: Net profit decline of Rs 22.40 crore from Q2FY26 to Q4FY26; execution stress visible in quarterly data.